SCHEMBL7945557

SCHEMBL7945557

FC(F)(F)c1ccccc1Oc1cc[c]cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX1 Q96LB2 2/20 0.39
KMT2A Q03164 2/20 0.39
HTR1A P08908 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
HPGD P15428 1/20 0.38
LTA4H P09960 1/20 0.37
PTGS2 P35354 1/20 0.37
POLB P06746 1/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
SCD O00767 1/20 0.34
P2RY1 P47900 1/20 0.34
SLC22A12 Q96S37 1/20 0.33
NOTUM Q6P988 1/20 0.33
MRGPRX4 Q96LA9 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3990742 0.87 KMT2A (0.34) KMT2AHPGDPOLBTSHRSMN1; SMN2
SCHEMBL3988351 0.83 TSHR (0.36) TSHRSMN1; SMN2
SCHEMBL3994095 0.81 L3MBTL1 (0.39) KMT2ASLC6A4HPGDPOLBRXRA
SCHEMBL3992362 0.81 KMT2A (0.37) KMT2ASLC6A4HPGDPOLBRXRA
SCHEMBL1711665 0.79 MEN1 (0.53) MRGPRX1KMT2AHTR1ASLC6A2SLC6A3
SCHEMBL19994256 0.77 KDM4E (0.51) MRGPRX1KMT2AHTR1ASLC6A2SLC6A4
SCHEMBL2897755 0.76 SMN1; SMN2 (0.55) MRGPRX1KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL693585 0.76 KMT2A (0.49) KMT2AHTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL919536 0.75 LTA4H (0.48) MRGPRX1HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL2753021 0.73 TRPA1 (0.40) KMT2AHTR1ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235758-B1 CENTRAL NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2001-05-22 US disclosed
EP-0808312-B1 INDOLE DERIVATIVES AS 5-HT RECEPTOR ANTAGONIST SMITHKLINE BEECHAM PLC (GB) 2000-11-02 EP disclosed
US-5990133-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS SUCH AS ANXIETY OR DEPRESSION SMITHKLINE BEECHAM P.L.C. (GB) 1999-11-23 US disclosed